If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

India took a much-needed step in the fight against obesity and diabetes with the introduction of Mounjaro (tirzepatide), a ...

The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a significant weight. In recent months, it’s become desirable among those who ...

Eli Lilly launches Mounjaro in India addressing diabetes-obesity crisis. Approved by CDSCO yet high costs limit accessibility ...

US pharma giant Eli Lilly's obesity management drug Mounjaro has now been launched in India. Interestingly, compared to the US, the price of Mounjaro in India will be one-fifth. Apart from obesity, ...

This was also up from the level in January. All four major US regions logged price increases. The popular 30-year fixed-rate mortgage averaged around 6.8 percent as of February 27, just slightly lower ...

In a single-dose vial presentation Eli Lilly, a pharmaceutical firm has announced the launch of Mounjaro, following the authorization ... As of 2023, adult obesity prevalence in India stood at around ...

Side effects and risks According to the company’s website, like any medication, Mounjaro comes with potential side effects ... The survey shows that in the category of ages 15-49 years, 6.4 per cent ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

With diabetes and obesity cases surging in India, pharmaceutical giant Eli Lilly and Company (India) has launched Mounjaro (tirzepatide ... obesity is increasing, with 6.5% of Indian adults ...

With similar drugs sparking debate over side-effects and real-world efficacy, is Mounjaro truly a breakthrough, or just another pharmaceutical trend? While Mounjaro has shown promising results, ...